Gadoterate Meglumine
NDC 65219-088, gadoterate meglumine, injection, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-088
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215982
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GADOTERATE MEGLUMINE376.9 mg/mL
Pharmacologic classes
Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-088-50 | 65219008850 | 6 CARTON in 1 BOX (65219-088-50) / 1 VIAL in 1 CARTON (65219-088-06) / 100 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/fbebe7f2-a0c2-4fd5-b421-8fbcbaf46709Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-088
Use it
Look up 65219-088 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.